Abstract
APP Pharmaceuticals' Abbreviated New Drug Application (ANDA) for injectable polymyxin B (500 000 units/vial) has been approved by the US FDA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have